Efficacy and Safety of Telmisartan Compared With Losartan

Clinical trial NCT06431477 · UNKNOWN

Trial details

NCT number: NCT06431477
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Nephropathies Hypertension

Start date: 2023-04-19
Primary completion: 2025-10-31
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.